Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium

UNC Libraries(2024)10.17615/hwqw-2381Source: DataRank Database

E-cadherin breast tumor expression, risk factors and survival: Pooled analysis of 5,933 cases from 12 studies in the Breast Cancer Association Consortium is a research paper published in UNC Libraries (2024). On theSindex it has a DataRank of 0.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access0 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (13 grants)OA: goldTopics (33)IDs (PubMed)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (52)

R.A.E.M. Tollenaar,Carolien H. M. van Deurzen ORCID,Montserrat García‐Closas ORCID,U Eilber,Minouk J. Schoemaker ORCID

Live enrichment

PubMed:30945415

National Institutes of Health

Grant: 5R01CA192393-02

Risk and penetrance of mutations from breast cancer testing panels.

National Institutes of Health

Grant: 1R01CA116167-01A1

BRCA2 missense mutations and breast cancer

National Health and Medical Research Council (NHMRC)

Grant: 400281

Molecular Epidemiology of Ovarian Cancer: The Australian Ovarian Cancer Study National Clinical Follow-Up Core

National Health and Medical Research Council (NHMRC)

Grant: 400413

Australian Ovarian Cancer Study (AOCS): A multidisciplinary ovarian cancer resource for the genomic era

National Institutes of Health

Grant: 5KL2TR000136-09

Mayo Clinic Center for Clinical and Translational Science (CCaTS)

National Institutes of Health

Grant: 5R01CA176785-05

Identifying and validating novel susceptibility genes for breast cancer

National Institutes of Health

Grant: 5UL1TR000135-08

Mayo Clinic Center for Clinical and Translational Science (CCaTS)

European Commission

Grant: 634935

Breast Cancer Risk after Diagnostic Gene Sequencing (BRIDGES)

National Health and Medical Research Council (NHMRC)

Grant: 199600

Towards cancer control: Population and molecular strategies

European Commission

Grant: 223175

Collaborative Oncological Gene-environment Study

European Commission

Grant: 633784

Breast CAncer STratification: understanding the determinants of risk and prognosis of molecular subtypes

Netherlands Organisation for Scientific Research (NWO)

Grant: 18886

Network situational awareness via real-time traffic analysis

Research Council of Finland

Grant: 266528

Comprehensive analysis of hereditary breast and ovarian cancer

goldLicense: CC BY

https://doi.org/10.1038/s41598-018-23733-4

https://www.nature.com/articles/s41598-018-23733-4.pdf

https://dx.doi.org/10.17615/hwqw-2381

https://dx.doi.org/10.17863/cam.23920

https://pubmed.ncbi.nlm.nih.gov/29700408

Fields of Study

0301 basic medicine03 medical and health sciences0303 health sciences

Keywords

Adult610Gene ExpressionBreast NeoplasmsErb-b2 Receptor Tyrosine KinasesArticlebreast cancerSDG 3 - Good Health and Well-beingRisk FactorsReceptorsJournal ArticleBiomarkers, TumorOdds RatioHumansProgesteroneerbB-2AgedProportional Hazards ModelsTumorMiddle AgedCadherinsPrognosisEstrogenReceptors, EstrogenCase-Control StudiesFemaleEMC MM-03-86-01Receptors, ProgesteroneBiomarkersReceptor

Sustainable Development Goals

SDG 3: 3. Good health